Ionis Pharmaceuticals (IONS) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Ionis Pharmaceuticals (IONS) over the last 11 years, with Q4 2024 value amounting to $97.7 million.
- Ionis Pharmaceuticals' Accumulated Depreciation & Amortization rose 1083.68% to $97.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $97.7 million, marking a year-over-year increase of 1083.68%. This contributed to the annual value of $97.7 million for FY2024, which is 1083.68% up from last year.
- Ionis Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $97.7 million in Q4 2024, which was up 1083.68% from $88.2 million recorded in Q4 2023.
- Ionis Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $97.7 million for Q4 2024, and its period low was $64.3 million during Q4 2020.
- For the 5-year period, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $81.8 million, with its median value being $79.6 million (2021).
- In the last 5 years, Ionis Pharmaceuticals' Accumulated Depreciation & Amortization soared by 2623.3% in 2020 and then tumbled by 55.79% in 2022.
- Ionis Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $64.3 million in 2020, then increased by 23.75% to $79.6 million in 2021, then dropped by 0.56% to $79.1 million in 2022, then increased by 11.43% to $88.2 million in 2023, then rose by 10.84% to $97.7 million in 2024.
- Its Accumulated Depreciation & Amortization was $97.7 million in Q4 2024, compared to $88.2 million in Q4 2023 and $79.1 million in Q4 2022.